Get the Stockscreener App
0.2278
0.96%
-0.0022
After Hours:
.23
0.0022
+0.97%
Adial Pharmaceuticals Inc stock is traded at $0.2278, with a volume of 208.15K.
It is down -0.96% in the last 24 hours and down -2.02% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$0.23
Open:
$0.243
24h Volume:
208.15K
Relative Volume:
0.56
Market Cap:
$6.33M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.0394
EPS:
-5.78
Net Cash Flow:
$-7.34M
1W Performance:
+5.32%
1M Performance:
-2.02%
6M Performance:
-55.68%
1Y Performance:
-76.03%
1-Day Range:
$0.225
$0.243
1-Week Range:
$0.2105
$0.2442
52-Week Range:
$0.21
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.2278 | 6.39M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
Treasury Yields: Will Adial Pharmaceuticals Inc benefit from government policyJuly 2025 Macro Moves & Technical Confirmation Alerts - baoquankhu1.vn
Published on: 2026-01-22 22:09:40 - baoquankhu1.vn
Lobbying Update: $10,000 of ADIAL PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
Returns Recap: Whats the MACD signal for Adial Pharmaceuticals IncJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045 - Sahm
Adial Pharmaceuticals (ADIL) Secures Patent Application for AD04, Aiming for Long-term Protection - GuruFocus
Adial Pharmaceuticals Announces Publication of International Patent Application for Lead Alcohol Use Disorder Therapy AD04 - Quiver Quantitative
New patent aims to shield alcohol use disorder drug AD04 through 2045 - Stock Titan
Can Adial Pharmaceuticals Inc. stock continue upward trendQuarterly Growth Report & Technical Entry and Exit Tips - Улправда
Is Adial Pharmaceuticals Inc. stock positioned well for digital economy2025 Stock Rankings & Daily Profit Focused Stock Screening - Улправда
Is Adial Pharmaceuticals Inc. stock affected by interest rate hikesJuly 2025 Summary & Fast Exit/Entry Strategy Plans - Улправда
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr. - Investing.com India
Adial Pharmaceuticals announces immediate resignation of board director - TipRanks
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr. By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Announces Board Resignation - TradingView — Track All Markets
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Pullback Watch: Will Adial Pharmaceuticals Inc stock benefit from M A activityWeekly Trade Analysis & Precise Buy Zone Identification - moha.gov.vn
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreases By 31.2% - Defense World
AXIM Biotechnologies (OTCMKTS:AXIM) versus Adial Pharmaceuticals (NASDAQ:ADIL) Financial Comparison - Defense World
Will Adial Pharmaceuticals Inc. stock split again soon2025 Macro Impact & Low Volatility Stock Recommendations - Улправда
Published on: 2025-12-20 18:07:08 - Улправда
Is Adial Pharmaceuticals Inc. stock cheap at current valuationMarket Activity Report & Technical Confirmation Alerts - Улправда
Published on: 2025-12-19 03:23:09 - Улправда
Will Adial Pharmaceuticals Inc. stock deliver shareholder valueStop Loss & Reliable Volume Spike Alerts - Улправда
[EFFECT] ADIAL PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Adial Pharmaceuticals Earnings Notes - Trefis
Volume Recap: Why Adial Pharmaceuticals Inc stock could be next big winner2025 Momentum Check & Consistent Return Strategy Ideas - moha.gov.vn
Litchfield Hills Research Weighs in on ADIL FY2025 Earnings - Defense World
Adial Pharmaceuticals Secures $2.86M Through Warrant Agreement - MSN
Adial Pharmaceuticals, Inc. (ADIL) AI-Powered Stock Analysis - Meyka
How Adial Pharmaceuticals Inc. stock benefits from strong dollarMarket Performance Report & Weekly Return Optimization Plans - Newser
Can Adial Pharmaceuticals Inc. stock attract ESG capital inflowsPortfolio Return Summary & Low Risk Investment Opportunities - Newser
Whale Trades: Can Adial Pharmaceuticals Inc. stock continue upward trendPortfolio Update Summary & Low Risk Growth Stock Ideas - moha.gov.vn
Are Smart Investors Making the Right Decision? Adial Pharmaceuticals Inc (ADIL) - Setenews
Adial Pharmaceuticals raises $2.86 million through warrant exercise By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals (ADIL) Announces Warrant Inducement Agreem - GuruFocus
Adial Pharmaceuticals raises $2.86 million through warrant exercise - Investing.com
Adial Pharmaceuticals Enters Warrant Inducement Agreement for $2.86 Million Capital Raise - Quiver Quantitative
Adial Pharmaceuticals (NASDAQ: ADIL) enters $2.86M inducement at $0.31 exercise price - Stock Titan
Is Adial Pharmaceuticals Inc a good long term investmentMoving Average Crossovers & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
Why Adial Pharmaceuticals Inc. stock could rally in 20252025 Year in Review & Expert Verified Movement Alerts - newser.com
Will Adial Pharmaceuticals Inc. stock deliver strong dividend growthJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Why Adial Pharmaceuticals Inc. stock could benefit from AI revolutionProfit Target & Safe Capital Growth Plans - newser.com
What high frequency data says about Adial Pharmaceuticals Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):